Literature DB >> 10674882

Balance of cell proliferation and apoptosis in breast carcinogenesis.

E C Mommers1, P J van Diest, A M Leonhart, C J Meijer, J P Baak.   

Abstract

We determined the mitotic and apoptotic index through the spectrum of pre-invasive ductal breast lesions to invasive carcinoma in search of disturbances in the proliferation/cell death balance in breast carcinogenesis. Seventy-two pure pre-invasive ductal breast lesions (without invasive carcinoma) and 103 invasive breast carcinomas were used. The numbers of mitotic and apoptotic cells were microscopically counted in hematoxylin and eosin stained sections (MI and AI, respectively), and the ratio of the values of MI and AI was calculated for each individual case (M/A index). A distinction was made between well differentiated and poorly differentiated breast lesions, based on histological type and nuclear grade, to arrive at two plausible progression models for breast carcinogenesis. For the well differentiated breast lesions, the MI was rather equal for hyperplasias and well differentiated DCIS, but increased 6-fold from DCIS to well differentiated invasive carcinoma. The AI remained in the same range, resulting in a 4-fold increase of the M/A index. For the poorly differentiated breast lesions, a significant increase in MI and AI was found from hyperplasia to poorly differentiated DCIS. From DCIS to poorly differentiated invasive carcinoma, the MI increased significantly and the AI decreased 2-fold (n.s.), resulting in a 2.5-fold significant increase of the M/A index. In conclusion, the net increase of the number of cells in the transition from well differentiated pre-invasive to well differentiated invasive carcinoma is accompanied by an increase of cell proliferation rather than decrease in apoptosis, suggesting that in these lesions, proliferation related mechanisms are most important in carcinogenesis and progression. In contrast, in poorly differentiated breast lesions, decreased apoptosis seems to be also important in carcinogenesis and progression. At present, we are gathering patients with invasive breast cancer who had a previous biopsy with a pre-invasive lesion to obtain further more direct evidence for this hypothesis.

Entities:  

Mesh:

Year:  1999        PMID: 10674882     DOI: 10.1023/a:1006396103777

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  16 in total

Review 1.  Studies of apoptosis in breast cancer.

Authors:  M Parton; M Dowsett; I Smith
Journal:  BMJ       Date:  2001-06-23

2.  Endonuclease G promotes cell death of non-invasive human breast cancer cells.

Authors:  Alexei G Basnakian; Eugene O Apostolov; Xiaoyan Yin; Stanley O Abiri; Anna G Stewart; Amar B Singh; Sudhir V Shah
Journal:  Exp Cell Res       Date:  2006-09-20       Impact factor: 3.905

3.  p53 mutation in breast cancer. Correlation with cell kinetics and cell of origin.

Authors:  T Megha; F Ferrari; A Benvenuto; C Bellan; A V Lalinga; S Lazzi; S Bartolommei; G Cevenini; L Leoncini; P Tosi
Journal:  J Clin Pathol       Date:  2002-06       Impact factor: 3.411

4.  Hepatocellular carcinomas in native livers from patients treated with orthotopic liver transplantation: biologic and therapeutic implications.

Authors:  H Kirimlioglu; I Dvorchick; K Ruppert; S Finkelstein; J W Marsh; S Iwatsuki; A Bonham; B Carr; M Nalesnik; G Michalopoulos; T Starzl; J Fung; A Demetris
Journal:  Hepatology       Date:  2001-09       Impact factor: 17.425

Review 5.  Chemoprevention of breast cancer: implications for postmenopausal women.

Authors:  Carol J Fabian; Bruce F Kimler
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

6.  Differential expression of cell cycle and apoptosis related proteins in colorectal mucosa, primary colon tumours, and liver metastases.

Authors:  H H J Backus; C J Van Groeningen; W Vos; D F Dukers; E Bloemena; D Wouters; H M Pinedo; G J Peters
Journal:  J Clin Pathol       Date:  2002-03       Impact factor: 3.411

7.  RORα binds to E2F1 to inhibit cell proliferation and regulate mammary gland branching morphogenesis.

Authors:  Gaofeng Xiong; Ren Xu
Journal:  Mol Cell Biol       Date:  2014-06-02       Impact factor: 4.272

8.  Apoptotic activity in Libyan breast cancer.

Authors:  Jamela Boder; Fathi Abdalla; Mohamed Elfagieh; Abdelbaset Buhmeida; Yrjö Collan
Journal:  World J Surg Oncol       Date:  2012-06-08       Impact factor: 2.754

9.  Non-invasive proteomics-thinking about personalized breast cancer screening and treatment.

Authors:  Manuel Debald; Matthias Wolfgarten; Gisela Walgenbach-Brünagel; Walther Kuhn; Michael Braun
Journal:  EPMA J       Date:  2010-07-14       Impact factor: 6.543

10.  Identification of biomarkers in ductal carcinoma in situ of the breast with microinvasion.

Authors:  Yasuhiro Okumura; Yutaka Yamamoto; Zhenhuan Zhang; Tatsuya Toyama; Teru Kawasoe; Mutsuko Ibusuki; Yumi Honda; Ken-ichi Iyama; Hiroko Yamashita; Hirotaka Iwase
Journal:  BMC Cancer       Date:  2008-10-06       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.